Raymond James Financial Services Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $364K | Buy |
|
|||||
|
2024
Q2 | $267K | Sell |
|
|||||
|
2024
Q1 | $363K | Sell |
|
|||||
|
2023
Q4 | $519K | Sell |
|
|||||
|
2023
Q3 | $706K | Sell |
|
|||||
|
2023
Q2 | $1.07M | Sell |
|
|||||
|
2023
Q1 | $1.15M | Sell |
|
|||||
|
2022
Q4 | $1.1M | Sell |
|
|||||
|
2022
Q3 | $2.05M | Sell |
|
|||||
|
2022
Q2 | $2.29M | Buy |
|
|||||
|
2022
Q1 | $2.23M | Buy |
|
|||||
|
2021
Q4 | $2M | Sell |
|
|||||
|
2021
Q3 | $2.95M | Buy |
|
|||||
|
2021
Q2 | $2.9M | Buy |
|
|||||
|
2021
Q1 | $2.69M | Buy |
|
|||||
|
2020
Q4 | $1.31M | Buy |
|
|||||
|
2020
Q3 | $943K | Buy |
|
|||||
|
2020
Q2 | $900K | Buy |
|
|||||
|
2020
Q1 | $411K | Buy |
|
|||||
|
2019
Q4 | $326K | Sell |
|
|||||
|
2019
Q3 | $313K | Sell |
|
|||||
|
2019
Q2 | $428K | Sell |
|
|||||
|
2019
Q1 | $528K | Buy |
|